<html><style> .textDiv { width: 900px; border: 25px solid #58D3F7; padding: 25px; margin: 25px; font-family: 'Arial', Times, serif; font-size: 16px; text-align: justify;} .title { margin: 50px 50px 50px 25px; font-family: 'Arial', Times, serif; font-size: 40px; font-weight: bold; color:  #58D3F7; text-align: left;} </style><head></head><body><div class='title'>extractUncertainty_Unspecified</div><div class='textDiv'>IPO Lockup Expiration: ReWalk Robotics Ltd. - ReWalk Robotics (NASDAQ:RWLK) | Seeking Alpha March 11, 2015 concludes the 180-day lockup period for RWLK; at this point, RWLKâ€™s major pre-IPO shareholders will have a first chance to sell their shares.We've observed abnormal negative returns as high as -5.8% in the days preceding and following a firm's IPO lockup expiration.<span style='background-color: #A9E2F3'>While RWLK had a strong start to trading, the stock faces current declines; some may be ready to cash out and move on.</span>ReWalk Robotics (NASDAQ: RWLK ) - Sell or Short Recommendation - $15.75 PT When the lockup period ends for ReWalk Robotics, its pre-IPO shareholders, directors, and executives will have the chance to sell their 5.1 million shares .(A lockup period, according to SEC guidelines , is an agreed-upon period of time, usually 180 days, during which a firm's pre-IPO shareholders are barred from selling their holdings.This is to maintain a fair and stable early market for the new stock.)<span style='background-color: #A9E2F3'>The potential for a sudden increase in shares available in the open market may cause a significant decrease in the price of RWLK shares, opening an opportunity to short the stock.</span>ReWalk Robotics is a medical device firm, based in Israel, that has designed and developed an exoskeleton primarily to assist wheelchair-bound patients.The exoskeleton , named ReWalk, integrates tilt-sensor technology with an on-board computer and motion sensors resulting in a product that can help paraplegics walk.Currently, ReWalk is the only exoskeleton on the market that uses the tilt sensor that assists with self-initiated walking.The product is battery-powered, lightweight, and comes with motors at the joints to power hip and knee movements.Users can sit, stand and in some cases, ascend and descend stairs.ReWalk Robotics is currently working on the next generation, which is expected to be lighter, slimmer and contain a drive mechanism.<span style='background-color: #A9E2F3'>Through July 2014, the company had trained nearly 400 ReWalk clients .</span>In addition, ReWalk Robotics received clearance to market its ReWalk Personal system in the U.S. beginning June 2014.ReWalk sells its products directly in the United States and Germany, but uses distributors in other markets.The company has agreements with third-party distributors in the United Kingdom, Turkey, Thailand, Taiwan, Singapore, Russia, Korea, Japan, Italy, France, China and Austria.Founder, President and Chief Technical Officer Dr. Amit Goffer founded ReWalk in 2001, and he served as CEO until 2012.Prior to founding ReWalk, Dr. Goffer founded Odin Medical Technologies.Dr. Goffer has a B.Sc.in electrical and computer engineering from Technion in Israel, an M.Sc.in electrical and computer engineering from Tel Aviv University, and a Ph.D. in electrical and computer engineering from Drexel University.CEO and board member Larry Jasinski has been in his position since February 2012.His previous experience includes positions at Soteira, Cortek, and Boston Scientific Corporation.Mr. Jasinski holds a B.Sc.in marketing from Providence College and an MBA from the University of Bridgeport.ReWalk Robotics reported fourth quarter revenue on February 12, 2015.Highlights include : Total Revenue for 2014 reached $4.0 million, an increase from $1.6 million 2013.The company added 15 training centers in 2014: eight in the United States, four in Europe, and one each in Australia, New Zealand and Taiwan.The first two U.S. private insurance companies approved coverage for the ReWalk personal system.ReWalk Robotics faces competition primarily from other makers of medical exoskeletons, including Parker Hannifin (NYSE: PH ), Cyberdyne, Rex Bionics (LON:RXB) and Ekso Bionics (OTCQB: EKSO ).<span style='background-color: #A9E2F3'>The company differentiates its product with the integration of the tilt-sensor technology that gives the user a self-initiated, more natural walking experience along with a lighter, slimmer design than comparable products.</span>Currently, the ReWalk Personal is the only FDA approved medical exoskeleton marketed in the U.S.In addition, patients have a choice of other alternative therapies and devices, such as treadmill-based therapies.Companies that offer these products and services include Reha Technology, Aretech, AlterG, and Hocoma.RWLK's IPO priced at $12, below its expected price range of $14 to $16.The stock closed on its first day of trading significantly higher at $25.60.It reached a high of $31.76 on September 15, 2014; however, the stock has declined significantly since then.It currently trades at $17.17 (3.02 pre-market).<span style='background-color: #A9E2F3'>Pre-IPO shareholders have a variety of reasons to sell at the expiration of the lockup period.</span><span style='background-color: #A9E2F3'>Some may be looking to take initial profits from RWLK's early successes, while others , such as firms SCP Vitalife Partners, Yaskawa Electric Corporation, Israel Healthcare Ventures, Entities affiliated with Pontifax, Entities affiliated with OurCrowd Investment, and Previs Ventures; could be looking to cash out and move on.</span><span style='background-color: #A9E2F3'>Additional investors, anticipating declines at this point, often sell in advance of a lockup expiration, further increasing supply.</span>We've researched this pattern extensively and found a bnormal negative returns to be as high as (-5.8%) in the eleven days prior and nine days following the event.<span style='background-color: #A9E2F3'>Combined, RWLK insiders , including six influential firms, and another several directors and executive officers, could effect a supply shock if they dump their holdings onto the open market, in turn depressing RWLK's share price.</span>These insiders currently hold 5.1 million shares of 8.2 million total.<span style='background-color: #A9E2F3'>If even a portion decide to sell, declines could be significant.</span><span style='background-color: #A9E2F3'>We suggest selling RWLK in advance of the event on 3.11 to take full advantage of declines.</span>We encourage readers wishing to join the discussion on IPOs to click +FOLLOW above the title of this article - and those wishing for the latest updates to click +Get real time alerts.Editor's Note: This article discusses one or more securities that do not trade on a major U.S. exchange.<span style='background-color: #A9E2F3'>Please be aware of the risks associated with these stocks.</span>Source: IPO Lockup Expiration: ReWalk Robotics Ltd.Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.(More...)The author wrote this article themselves, and it expresses their own opinions.The author is not receiving compensation for it (other than from Seeking Alpha).The author has no business relationship with any company whose stock is mentioned in this article.We only use your contact details to reply to your request for more information.We do not sell the personal contact data you submit to anyone else.Thank you for your interest in Seeking Alpha PRO We look forward to contacting you shortly for a conversation.Our PRO subscription service was created for fund managers, and the cost of the product is prohibitive for most individual investors.PRO Alerts is our flagship product for individual investors who want to be faster and smarter about their stocks.To learn more about it, click here.If you are an investment professional with over $1M AUM and received this message in error, click here and you will be contacted shortly.We look forward to contacting you when we have an individual investor product ready!</div></body></html>